Literature DB >> 11389046

Expression of macrophage inflammatory protein-3alpha, stromal cell-derived factor-1, and B-cell-attracting chemokine-1 identifies the tonsil crypt as an attractive site for B cells.

M Casamayor-Pallejà1, P Mondière, A Amara, C Bella, M C Dieu-Nosjean, C Caux, T Defrance.   

Abstract

The expression of 3 lymphoid chemokines-macrophage inflammatory protein-3alpha (MIP-3alpha), stromal cell-derived factor-1 (SDF-1), and B-cell-attracting chemokine-1 (BCA-1)-in the tonsil and the possible correlation between their sites of expression and B-cell localization within this tissue were studied. The results show that all 3 chemokines are produced in the crypts but differ by the nature of the cells that produce them and their location within the crypt. SDF-1 and MIP-3alpha are produced by epithelial cells, but their secretion is mutually exclusive. Both MIP-3alpha- and SDF-1-expressing cells are in close contact with memory B cells. By contrast, BCA-1-producing cells in the crypt are not epithelial and form clusters colocalized with plasma cells. Altogether, these data suggest that the chemokines produced in the tonsillar crypt may (1) attract memory B cells to antigen and (2) recruit and retain plasma cells and memory B cells within the supportive epithelial microenvironment of the crypt. (Blood. 2001;97:3992-3994)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389046     DOI: 10.1182/blood.v97.12.3992

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Ectopic lymphoid neogenesis in psoriatic arthritis.

Authors:  Juan D Cañete; Begoña Santiago; Tineke Cantaert; Raimon Sanmartí; Antonio Palacin; Raquel Celis; Eduard Graell; Beatriz Gil-Torregrosa; Dominique Baeten; José L Pablos
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 3.  Pathophysiology of retinal lymphoma.

Authors:  Sarah E Coupland; Chi Chao Chan; Justine Smith
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

4.  Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium.

Authors:  Sharof Tugizov; Rossana Herrera; Piri Veluppillai; John Greenspan; Deborah Greenspan; Joel M Palefsky
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells.

Authors:  Fabien Agenès; Nabil Bosco; Laurent Mascarell; Sabrina Fritah; Rod Ceredig
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

Review 6.  CCR6 as a mediator of immunity in the lung and gut.

Authors:  Toshihiro Ito; William F Carson; Karen A Cavassani; Judith M Connett; Steven L Kunkel
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

7.  Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?

Authors:  Eric Vivier; Hergen Spits; Tom Cupedo
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

8.  Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.

Authors:  Barbro Ehlin-Henriksson; Frida Mowafi; George Klein; Anna Nilsson
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

9.  Gene expression patterns in bone following mechanical loading.

Authors:  Sara M Mantila Roosa; Yunlong Liu; Charles H Turner
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

Review 10.  Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.

Authors:  Olivier Garraud; Gwenoline Borhis; Gamal Badr; Séverine Degrelle; Bruno Pozzetto; Fabrice Cognasse; Yolande Richard
Journal:  BMC Immunol       Date:  2012-11-29       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.